Skip to main content

Animations

MJFF Publications

501 - 510 of 6516 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-06457-2
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s13311-022-01199-7
    Citation Count: 24
  • Summary Details
    OPEN
    Title: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    Journal Name: PharmacoEconomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40273-022-01132-y
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-07706-2
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Leveraging Patient Preference Information in Medical Device Clinical Trial Design
    Journal Name: Therapeutic Innovation & Regulatory Science
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s43441-022-00450-9
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The silver linings of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00283-1
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20126
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Dancing Feet Dyskinesia in a Patient with GBA-PD
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20169
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Physical activity and exercise for people with Parkinson’s
    Journal Name: Advances in Clinical Neuroscience & Rehabilitation
    Publisher: Whitehouse Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.47795/fenh4822
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.